Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C33H40N6O7 |
| Molecular Weight | 632.7067 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H](C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(N)=O
InChI
InChIKey=XDRHVZLDLNGKLM-FLVVDCEDSA-N
InChI=1S/C33H40N6O7/c1-19(36-32(45)26(34)16-22-8-12-24(40)13-9-22)31(44)39-28(18-21-6-4-3-5-7-21)33(46)37-20(2)30(43)38-27(29(35)42)17-23-10-14-25(41)15-11-23/h3-15,19-20,26-28,40-41H,16-18,34H2,1-2H3,(H2,35,42)(H,36,45)(H,37,46)(H,38,43)(H,39,44)/t19-,20-,26+,27+,28+/m1/s1
| Molecular Formula | C33H40N6O7 |
| Molecular Weight | 632.7067 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Casokefamide is a synthetic peptide derived from the beta-casomorphin sequence, designed to increase the resistance to gastric proteases. . Casokefamide binds to both mu and delta-opioid receptors, while beta-casomorphins and its fragments are typical mu-opioid receptor agonists. Furthermore, casokefamide can affect gastric acid and pancreatic exocrine secretions and also gastrointestinal motility.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/m/pubmed/10793229/
16.0 mg/day
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:29:10 GMT 2025
by
admin
on
Mon Mar 31 18:29:10 GMT 2025
|
| Record UNII |
B453T1E8MP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
98815-38-4
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
PRIMARY | |||
|
5464104
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
PRIMARY | |||
|
Casokefamide
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
PRIMARY | |||
|
C77281
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
PRIMARY | |||
|
DTXSID30243827
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106384
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
PRIMARY | |||
|
C047075
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
PRIMARY | |||
|
SUB06157MIG
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
PRIMARY | |||
|
100000081353
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
PRIMARY | |||
|
6808
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
PRIMARY | |||
|
B453T1E8MP
Created by
admin on Mon Mar 31 18:29:10 GMT 2025 , Edited by admin on Mon Mar 31 18:29:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |